SYS6023 Clinical Trials

2 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

CSPC Megalith Biopharmaceutical Co.,Ltd.2

Indications

Cancer2
Advanced Breast Cancer1
Advanced Solid Tumor1
Breast Cancer1

Other2 trials

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

Phase 2

A Clinical Study of SYS6023 in Patients With Advanced Solid Tumors

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.